Drug shortage: Furosemide Injection (HYDRALAZINE HYDROCHLORIDE, FUROSEMIDE)
FDA lists 30 presentations as Current. Availability: Unavailable (11), Available (16). Reason: Discontinuation of the manufacture of the drug; Demand increase for the drug. Companies: Meitheal Pharmaceuticals, Inc., Gland Pharma Limited, Hospira, Inc., a Pfizer Company, Eugia US LLC, Avet Pharmaceuticals, Inc.….
- Published by source
- 2020-04-07
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Meitheal Pharmaceuticals, Inc.
- Products
- Furosemide Injection HYDRALAZINE HYDROCHLORIDE FUROSEMIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Check wholesalers for inventory
- Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-04-07
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #882 | new | 2026-10-22 | 08018f758206…08ec3f | 0cc588757925…efd7d0 |
| #1163 | update | 2026-10-23 | dc7c144b9bff…2bd5eb | 27f7e16e0056…cd93a7 |
Chain head: #1250 0c9a4a81d7d8…29590d